Franziska E. Marquard

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survival.

Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survival.

Journal: Bone marrow transplantation

Published: November 13, 2025

Belumosudil for Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-Analysis.

Belumosudil for Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-Analysis.

Journal: Transplantation and cellular therapy

Published: October 03, 2025

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Journal: Blood

Published: August 01, 2025

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Journal: Blood

Published: August 01, 2025

Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantation.

Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantation.

Journal: Bone marrow transplantation

Published: March 25, 2025

Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCT.

Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCT.

Journal: Bone marrow transplantation

Published: March 25, 2025

Clearance of Driver Mutations after Transplantation for Myelofibrosis.

Clearance of Driver Mutations after Transplantation for Myelofibrosis.

Journal: The New England journal of medicine

Published: January 08, 2025

Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for Myelofibrosis.

Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for Myelofibrosis.

Journal: American journal of hematology

Published: September 11, 2024

Multiple myeloma in the young: insights on prognosis, clinical features and treatment outcome derived from nationwide German registry data and a nested multicenter sample.

Multiple myeloma in the young: insights on prognosis, clinical features and treatment outcome derived from nationwide German registry data and a nested multicenter sample.

Journal: Haematologica

Published: April 11, 2024

Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.

Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.

Journal: Bone marrow transplantation

Published: January 14, 2024

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment.

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment.

Journal: Frontiers in oncology

Published: September 04, 2023

PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.

PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.

Journal: Biochemical pharmacology

Published: August 21, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026